Joined March 2026
- Tweets 94
- Following 444
- Followers 29
- Likes 611
51 Photos and videos
Bio (bio/acc) π« retweeted
most people still donβt understand whatβs happening
>~75% age reversal in animals in weeks (David Sinclair)
>first human trials for age-reversal pathways FDA greenlight is underway
>AI is compressing bio timelines by an order of magnitude
the curve already bent in Q1 2026
brace for bio/acc, the acceleration will be brutal.
Mar 17
π¨ Futurist Ray Kurzweil predicts: by 2030, humans could be closer than ever to immortality, thanks to nanobots.
Rayβs been right about ~86% of his past predictions. This could be his boldest yet.
91
192
2,251
165,429
Bio (bio/acc) π« retweeted
Mar 17
π¨BREAKING: Scientists have created the first artificial Neuron capable of communicating with the Human Brain.
25
81
553
14,504
Bio/acc @beffjezos π«π«π«
@0xLuxi @0xRichNormie @_logjam @_Shadow36 @andy8052 @pattyice @Flowslikeosmo @AndyAyrey @Kalshi @Bancrypto__ @frankcastleeth @MEXC_Official @himothy @henrys0x @DipWheeler @traderpow @m_goes_distance π«π«π«
x.com/i/status/2030767821131β¦
3
Bio (bio/acc) π« retweeted
Mar 16
bio/acc!
Mar 15
π¨: A GIANT LEAP TOWARDS IMMORTALITY
Scientists successfully tranfer a longevity gene, paving the way for extension of human lifespan.
2
1
6
651
Bio (bio/acc) π« retweeted
Mar 10
Biotech is only going up, and bio/acc will follow!
bio/acc is the movement of biotech, to make it programmable and infinitely faster.
we are the bio/acc community on solana. each breakthrough in biotech sends bio/acc even further.
lock in, nothing will stop us soon!
CLP3exiqE8drZSzwhPas257cTh1evzq6nr7i1Xwvpump
1
7
41
6,596
Bio/acc @beffjezos π«π«π«
@0xLuxi @0xRichNormie @_logjam @_Shadow36 @andy8052 @pattyice @Flowslikeosmo @AndyAyrey @Kalshi @Bancrypto__ @frankcastleeth @MEXC_Official @himothy @henrys0x @DipWheeler @traderpow
x.com/i/status/2032883677311β¦
brutally bio/acc
2
Bio (bio/acc) π« retweeted
It's genuinely insane how much progress biotech has made in the last 90 days:
- Two years ago I watched Lucy Therapeutics shut down after 7 years and $42M from Bill Gates, never reached human trials. Last month DeSci crowdfunded β¬2.5M in 72 hours for Dr Barbacid cancer trials and went straight to human trials. Zero VCs and zero committees in the middle. And it's not even about the money. The goodwill
- Gene therapy cost $2-4M per treatment a year ago because manufacturing was artisanal and nobody was actually solving it. Now automation's dropping costs toward $200. Turns out it was an engineering problem all along.
- Just a year ago, the FDA wouldn't touch longevity.
In January 2026, first FDA-approved human trial reversing cellular age launched (ER-100). We're testing age reversal in humans right now. Not mice.
- Psychedelics stuck in regulatory hell for 50 years.
In February 2026, Compass crushed Phase III for psilocybin in treatment-resistant depression.
- In 2023, AI drug discovery was hype. $17B got invested, zero approved drugs.
Early 2026, Ginkgo x OpenAI ran over 200k autonomous experiments, 36K of those were unique. Protein costs dropped by 40% and they're already shipping commercially. Discovery timelines collapsed.
- Just last year, FDA required full GMP pre-Phase 2, moved at 1950s speed. This quarter,we're fast-tracking frontier therapies, relaxing requirements, launching pilots. Something shifted and the regulatory wall is cracking.
- In 2024, clinical trials had to run in US at 2x cost, half the speed. Right now in Singapore and China running trials 50% cheaper, 2x faster. Companies routing around FDA entirely. The US model is optional.
I could keep going on with these, but you realize that the bottleneck was never the science. It was funding models, regulatory speed, manufacturing, geography etc
And most of them are breaking since last October.
Biotech has shed 30 years of broken infrastructure in 5 months and I can't be more bullish.
bio/acc.
31
80
649
63,940
Bio (bio/acc) π« retweeted
we hit 30k. wild.
here's your 2026 biotech recap so far:
- the FDA just cleared the first human trial to reverse cellular age. not slow it, reverse it.
- NewLimit raised $130M to reprogram your biology like a software update
- IVF clinics are now selling embryo IQ and trait scoring. the He Jiankui stuff normalized more than anyone admits
- turns out the obesity drug is also a brain aging drug. GLP-1s protect neurons, cut inflammation, preserve memory. oops.
- $230M just went into putting a chip under your retina to restore vision
- a Sydney guy just used ChatGPT AlphaFold to design a personalized cancer vaccine for his dog from scratch. tumor down 75% in a month. yesterday.
- China now runs more clinical trials than the US. first time ever. we are losing this race in slow motion.
- new CRISPR that activates genes without cutting DNA, opens up 80% of conditions the old version couldn't touch
and we're not even halfway through March.
bio/acc.
11
34
269
11,777
Bio/acc @beffjezos π«π«π«
@0xLuxi @0xRichNormie @_logjam @_Shadow36 @andy8052 @pattyice @Flowslikeosmo @AndyAyrey @Kalshi @Bancrypto__ @frankcastleeth @MEXC_Official @himothy @henrys0x @DipWheeler @traderpow @m_goes_distance π«π«π«
x.com/i/status/2032883677311β¦
Mar 8
Having known @michaelandregg for a few years, it's been extremely exciting to track his team's progress @eonsys
Absolutely next-level effort to scan and simulate brains
This is the sort of bio/acc the world needs
See thread below (worth a read)
8
Bio/acc @beffjezos π«π«π«
@0xLuxi @0xRichNormie @_logjam @_Shadow36 @andy8052 @pattyice @Flowslikeosmo @AndyAyrey @Kalshi @Bancrypto__ @frankcastleeth @MEXC_Official @himothy @henrys0x @DipWheeler @traderpow @0xAso_btc
This is extremely bullish
ChatGPT $3,000 = custom cancer therapy
>tech guy adopts rescue dog with terminal cancer
>sequences the tumor DNA
> feeds it into ChatGPT AlphaFold
> identifies mutated proteins
> designs a custom mRNA vaccine
> even waits longer for ethics approval than building the therapy
> drives 10 hours to give the first shot
tumor shrinks, dog survives.
the pharma pipeline just got a new competitor:
determined humans with AI.
bio/acc
5
Bio/eacc @beffjezos π«π«π«
@0xLuxi @0xRichNormie @_logjam @_Shadow36 @andy8052 @pattyice @Flowslikeosmo @AndyAyrey @Kalshi @Bancrypto__ @frankcastleeth @MEXC_Official @himothy @henrys0x
This is extremely bullish
ChatGPT $3,000 = custom cancer therapy
>tech guy adopts rescue dog with terminal cancer
>sequences the tumor DNA
> feeds it into ChatGPT AlphaFold
> identifies mutated proteins
> designs a custom mRNA vaccine
> even waits longer for ethics approval than building the therapy
> drives 10 hours to give the first shot
tumor shrinks, dog survives.
the pharma pipeline just got a new competitor:
determined humans with AI.
bio/acc
11
Bio (bio/acc) π« retweeted
Mar 12
Greatest cultural movement of the 21st century. Donβt forget that @frankcastleeth called $e/acc sub 100k before it rallied to 30m .
I hope you are taking advantage of the massive mispricing that still exists.
Bounce/acc on my $bio/acc.
1
7
106
Bio (bio/acc) π« retweeted
Mar 8
Having known @michaelandregg for a few years, it's been extremely exciting to track his team's progress @eonsys
Absolutely next-level effort to scan and simulate brains
This is the sort of bio/acc the world needs
See thread below (worth a read)
We've uploaded a fruit fly. We took the @FlyWireNews connectome of the fruit fly brain, applied a simple neuron model (@Philip_Shiu Nature 2024) and used it to control a MuJoCo physics-simulated body, closing the loop from neural activation to action.
A few things I want to say about what this means and where we're going at @eonsys. π§΅
16
36
362
54,298
When the Space Will Connect the dots I can say everything Will return to bio/acc
This is extremely bullish
ChatGPT $3,000 = custom cancer therapy
>tech guy adopts rescue dog with terminal cancer
>sequences the tumor DNA
> feeds it into ChatGPT AlphaFold
> identifies mutated proteins
> designs a custom mRNA vaccine
> even waits longer for ethics approval than building the therapy
> drives 10 hours to give the first shot
tumor shrinks, dog survives.
the pharma pipeline just got a new competitor:
determined humans with AI.
bio/acc
1
1
7
454
Yoo @CryptoGatsu can you work on axiom for update xcom and tg , when we click on , we have the website like with manifesto
1
1
3
365
Bio (bio/acc) π« retweeted
Mar 11
bio/acc
everywhere
It's genuinely insane how much progress biotech has made in the last 90 days:
- Two years ago I watched Lucy Therapeutics shut down after 7 years and $42M from Bill Gates, never reached human trials. Last month DeSci crowdfunded β¬2.5M in 72 hours for Dr Barbacid cancer trials and went straight to human trials. Zero VCs and zero committees in the middle. And it's not even about the money. The goodwill
- Gene therapy cost $2-4M per treatment a year ago because manufacturing was artisanal and nobody was actually solving it. Now automation's dropping costs toward $200. Turns out it was an engineering problem all along.
- Just a year ago, the FDA wouldn't touch longevity.
In January 2026, first FDA-approved human trial reversing cellular age launched (ER-100). We're testing age reversal in humans right now. Not mice.
- Psychedelics stuck in regulatory hell for 50 years.
In February 2026, Compass crushed Phase III for psilocybin in treatment-resistant depression.
- In 2023, AI drug discovery was hype. $17B got invested, zero approved drugs.
Early 2026, Ginkgo x OpenAI ran over 200k autonomous experiments, 36K of those were unique. Protein costs dropped by 40% and they're already shipping commercially. Discovery timelines collapsed.
- Just last year, FDA required full GMP pre-Phase 2, moved at 1950s speed. This quarter,we're fast-tracking frontier therapies, relaxing requirements, launching pilots. Something shifted and the regulatory wall is cracking.
- In 2024, clinical trials had to run in US at 2x cost, half the speed. Right now in Singapore and China running trials 50% cheaper, 2x faster. Companies routing around FDA entirely. The US model is optional.
I could keep going on with these, but you realize that the bottleneck was never the science. It was funding models, regulatory speed, manufacturing, geography etc
And most of them are breaking since last October.
Biotech has shed 30 years of broken infrastructure in 5 months and I can't be more bullish.
bio/acc.
1
3
13
979